The Valley Desk

NCT00578175 · Interventional trial

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Overall registry status Completed

Phase 2

Conditions Measles, Mumps, Rubella, Varicella

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov